chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Skin reaction with pain and redness to U Rt arm. Benadryl at night/apply ice/watch for worsening symptoms.
Severe itching, swelling, and redness at the injection site extending in a 4-5 inch wide area over the upper arm; no fever, no chills, no nausea or vomiting, no headache; on day 6 the reaction is still present but greatly diminished
This case was reported by a consumer via other manufacturer and described the occurrence of allergic reaction in a adult male patient who received Flu Season TIV Dresden. Co-suspect products included VIOMYCIN and polymyxin b. On an unknown date, the patient received Seasonal Influenza vaccine at an unknown dose, VIOMYCIN at an unknown dose and frequency and polymyxin b at an unknown dose and frequency. On an unknown date, an unknown time after receiving Seasonal Influenza vaccine, the patient experienced allergic reaction. The action taken with VIOMYCIN was unknown. The action taken with polymyxin b was unknown. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to Seasonal Influenza vaccine. Additional details were provided as follows: The patient received Flu vaccine and experienced allergic reaction to that. The patient mentioned he had an allergy to VIOMYCIN or polymyxin b and was just wondering if it would be safe to get the PREVNAR 13.
This 6 year old patient received a Pfizer Bivalent Covid Booster age 12 yo and greater.  Patient mother was contacted all questions were answered to mother's satisfaction.  Mother verbalized understanding.  Patient had no adverse events at this time.  Patient Provider was contacted.
patient states it was like how he reacts to coconut. Throat swelling and tongue swelling. went to emergency room and they administered Benadryl and Prednisone. Patient sates swelling subsided and no issues since then
I AM THE PATIENT FILLING OUT THIS FORM AND I JUST CHOSE ANY MANUFACTURER AS I DO NOT KNOW IN ORDER TO BE ABLE TO COMPLETE FORM AND SUBMIT.  THE ISSUE HERE IS THAT THE FACILITY IS UNEDUCATED ON THE NUMBER OF PPV VACCINATIONS A PERSON SHOULD RECEIVED!  Approximately 12 hours after receiving a 3rd PPV vaccination (previously received in 1997, 2002) my left arm where the vaccine was administered blew up to twice its normal size with extreme localized pain.  24 hours after that, the area was bright red and the redness continued to progress in a band across the deltoid area of my upper arm where the vaccine site was.  It was extremely painful as well.  My axillary lymph node and left breast were also painful.  It is still slightly red and painful almost 4 days later.  We were given a PPV sheet to read, however were called in to have the vaccine given, and we told them it was our 3rd shot, before we had time to fully read and understand the sheet.  This walk-in clinic needs much education on the PPV vaccine and should not be giving out without fully understanding it themselves.
Client recieved Pfizer Dose 1 on 09/12/2021  returned to site to recieve Pfizer Dose 2 on 10/03/2021. Immunization Record shows Janssen given on 03/29/2021. Client reports no severe adverse reaction to Pfizer Dose 1.
Leg very swollen from groin to knee, hot, red, hand, increased temp. Extreme local reaction 1 1/2 hrs onset from vaccine.
Headache, Myalgia, !st dose - sore arm x 2 days. After 2nd dose - sore arm x 2 days, also HA day of vaccine & fatigue the next day. Narrative:
Right side of face paralysis, unable to close right eye or smile, drooping corner of mouth.  Diagnosis : Bell's Palsy
Oral fever, 101.8 +8hrs Muscle and body tightness and soreness +8hrs Chills 5-6hrs Headache +8hrs Home treatment ongoing
Paleness, Dizziness, weakness, sweats.  No treatment went home to bed.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 22-DEC-2014 the patient was vaccinated with improperly stored PNEUMOVAX23 (lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pain the scrotum extreme heat in the back of the sack  feeling of a cut in the back of the scrotum
Headache; Dizziness; Heart Palpitations; difficulty breathing; This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (Dizziness), PALPITATIONS (Heart Palpitations), DYSPNOEA (difficulty breathing) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Dizziness since 17-Jan-2021, Palpitations since 17-Jan-2021, Difficulty breathing since 17-Jan-2021, Dizziness since 17-Jan-2021 and Headache since 17-Jan-2021.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced DIZZINESS (Dizziness), PALPITATIONS (Heart Palpitations) and DYSPNOEA (difficulty breathing). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), PALPITATIONS (Heart Palpitations), DYSPNOEA (difficulty breathing) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Some of the fluids ran all the way down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow). On 17-Feb-2021, ACCIDENTAL UNDERDOSE (Some of the fluids ran all the way down to her elbow) had resolved. Not Provided          Relevant concomitant medications were not reported.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to -MODERNATX, INC.-MOD-2021-060914 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-060914:1st dose case
Hives/ Urticaria/ hives on the neck and abdomen then it spread from the neck and abdomen to everywhere/still having hives reaction; Itching on the scalp and ears/Itching; Allergies; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives/ Urticaria/ hives on the neck and abdomen then it spread from the neck and abdomen to everywhere/still having hives reaction), PRURITUS (Itching on the scalp and ears/Itching) and HYPERSENSITIVITY (Allergies) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067FZ1A, 011A21A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced PRURITUS (Itching on the scalp and ears/Itching) and HYPERSENSITIVITY (Allergies). On 02-Dec-2021, the patient experienced URTICARIA (Hives/ Urticaria/ hives on the neck and abdomen then it spread from the neck and abdomen to everywhere/still having hives reaction). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; LEVOCETIRIZINE DIHYDROCHLORIDE (ALLEGRA [LEVOCETIRIZINE DIHYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives/ Urticaria/ hives on the neck and abdomen then it spread from the neck and abdomen to everywhere/still having hives reaction), PRURITUS (Itching on the scalp and ears/Itching) and HYPERSENSITIVITY (Allergies) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. It's been a long time since patient was been on medications.
Vaginal discharge,clay discharge,discharge very dark color; suddenly felt like a gush,like the ones you have when you're in your period; clay mucus discharge, sticky, no odor; some pain in the left arm, the side that the vaccine was administrated; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL DISCHARGE (Vaginal discharge,clay discharge,discharge very dark color), FEELING ABNORMAL (suddenly felt like a gush,like the ones you have when you're in your period), SECRETION DISCHARGE (clay mucus discharge, sticky, no odor) and VACCINATION SITE PAIN (some pain in the left arm, the side that the vaccine was administrated) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007021-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2022, the patient experienced VAGINAL DISCHARGE (Vaginal discharge,clay discharge,discharge very dark color), FEELING ABNORMAL (suddenly felt like a gush,like the ones you have when you're in your period), SECRETION DISCHARGE (clay mucus discharge, sticky, no odor) and VACCINATION SITE PAIN (some pain in the left arm, the side that the vaccine was administrated). At the time of the report, VAGINAL DISCHARGE (Vaginal discharge,clay discharge,discharge very dark color), FEELING ABNORMAL (suddenly felt like a gush,like the ones you have when you're in your period), SECRETION DISCHARGE (clay mucus discharge, sticky, no odor) and VACCINATION SITE PAIN (some pain in the left arm, the side that the vaccine was administrated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication and treatment medication were provided.  It was reported that Patient was not sure about the Lot number since it was hand written and not sure it was a 0 between 7 and 2. Patient states Patient trying to read it, not seeing anything and seeing about menstrual period. Patient wanna know if that's one of the side effects it goes now. Patient mention that suddenly felt like a gush, like the ones you have when you're in your period, and went to look and find some clay mucus discharge, sticky, no odor. And this happened twice. Also patient state that has a perfect good health and not taking any Medication. AE related to 1dose.
4/6: Lethargy, sore arm. Toward evening, strong chills developed.. 4/7:  Awoke with slight headache and fatigue. Arm pain lessened. went to bed early. 4/8: Awoke feeling great. About 8 pm, felt my left arm itching. Looked in mirror and noticed red swelling at injection site and redness spread in appx 3-inch circle, Very itchy. Slept only 2 hours.  Throughout the night, also got mild cramps  in both my calves and bottom of my feet, about three times, which lasted only briefly. 4/9: Swelling and itching persisted upon waking and lingered throughout day. By 10:00 p.m., swelling and redness were nearly resolved and itching lessened. doctor contacted me to make sure the problem was resolving.
Information has been received from a male patient who on 31-JUL-2007 at 14:30 PM was vaccinated with a dose of Zostavax. About 12 hours after vaccination, on approximately 31-JUL-2007, the patient experienced deafness in right ear only. Additional information has been requested. Upon internal review deafness was considered to be an other important medical event.  9/14/07 Reviewed pcp medical records which reveal patient experienced tinnitus & hearing loss of right ear on the evening of vax, 8/31/07.  Seen by pcp again on 8/1 w/labyrinthitis, vertigo, nausea/vomiting & nystagmus..  Right ear exam otherwise WNL.  Tx w/decongestant, steroid taper & ear drops.  No improvement & was referred to ENT on 8/2.  ENT consult done 8/6 revealed patient still experiencing complete hearing loss of right ear & vertigo w/rapid change of head position. Right ear mildly occluded w/cerumen, left ear impacted w/cerumen, both w/tympanic membraes WNL. Referred for MRI of internal auditory canal to r/o neuroma.  Tx w/trial of melatonin.  FINAL DX: Sudden sensory hearing loss, right ear, idiopathic; hx of tinnitus; impacted cerumen. 9/28/07 Reviewed ENT eval of 8/6/07 which had been previously submitted by pcp. FINAL DX: Idiopathis sudden sensory neural hearing loss of right ear.
Within 15-30 min of admin this employee reported tachycardia (115 bpm) & lightheadedness, numb/tingly feet. O2 sats 96% & no c/o dyspnea. 911 called per employee request & she was taken to hospital.
Hive and rash from shingles injection (ZOSTAVAX). Red rash and swelling at injection site. Pt states took 1 day to develop and hives proceeded over entire body.
Fever; Chills; This case was reported by a consumer via sales rep and described the occurrence of fever in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced fever and chills. On an unknown date, the outcome of the fever and chills were unknown.   It was unknown if the reporter considered the fever and chills to be related to Bexsero.  Additional information was received as follows: The age at vaccination was not reported. The patient experienced fever and chills with no loss of consciousnesses after received Bexsero. Information about health care provider was not provided as the reporter did not have the information.Information about patient was not provided as the reporter did not have the information.
Patient called by phone and stated that about 24 hours after 1st vaccination on 4/19/2021, he experienced hearing loss in both ears on 4/20/2021 at about 10 a.m., which went away.  Then the next day on 4/21/2021 until today, April 25, 2021, he again experienced hearing loss in both ears, like it is plugged, and he currently is having a hard time hearing and has minor pain.
HEAD TREMORS; BLURRED VISION; CONSTANT MUSCLE FAILURE; FLU-LIKE SYMPTOMS; SEVERE MUSCLE WEAKNESS; INJECTION SITE SORENESS; WEAKNESS, NO ENERGY, NO STRENGTH; EMOTIONALLY  DEGRADING; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia, 1 pack per day medical marijuana a joint per day for pain, and non alcohol user, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821288, and expiry: 15-SEP-2021) dose was not reported, administered on 03-JUL-2021 11:00:00 for prophylactic vaccination. No concomitant medications were reported.  On JUL-2021, the subject experienced emotionally degrading. On 04-JUL-2021, the subject experienced head tremors. On 04-JUL-2021, the subject experienced blurred vision. On 04-JUL-2021, the subject experienced constant muscle failure. On 04-JUL-2021, the subject experienced flu-like symptoms. On 04-JUL-2021, the subject experienced severe muscle weakness. On 04-JUL-2021, the subject experienced injection site soreness. On 04-JUL-2021, the subject experienced weakness, no energy, no strength. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms, and weakness, no energy, no strength on 06-JUL-2021, had not recovered from injection site soreness, severe muscle weakness, head tremors, blurred vision, and constant muscle failure, and the outcome of emotionally degrading was not reported. This report was non-serious.
Evening after receiving vaccinations patient ended up in hospital with Pulse 131, increased blood pressure, acute attack of essential tremor, fever 101.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2022 at 4:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Feb-2022 at 4:04 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. Vaccine went into 2 to 8 degrees Celsius in thaw state on or about 24 Dec 2021. Patient received booster dose on 23-feb-2022 at 16:04:54. Patient ethnicity reported. The patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2-to-8-degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. We no longer possess this lot number. No treatment information was provided.
Patient noticed warmness and soreness of LEFT arm (the arm in which the influenza vaccine was administered) while shopping in the afternoon on 9/13/2016. She later noticed a red rash on her LEFT ARM. The rash was a few inches long and a couple inches wide. On 9/14, the rash already begin to decrease in size but the rash still was warm. For completeness, the right arm in which the Tdap was administered did NOT have any rash nor other side effects.
Patient complained of pain, swelling, stiffness, a bruise at injection site and a red streak on the underside of arm. She contacted the pharmacy 2 days after injection.
Left outer leg rash/lesion.  Mother stated rash same appearance as seen on tv for rash reaction to immunization.  8/26/08 Reviewed PCP medical records of 8/4/2008. FINAL DX: vascular rash Records reveal patient experienced left outer leg & back rash x 1 week. Received Hep A & Varicella vaccines tha
Diarrhea; Redness in the arm of the injection; Sensibility in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ERYTHEMA (Redness in the arm of the injection) and VACCINATION SITE REACTION (Sensibility in the arm of injection) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 01-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), ERYTHEMA (Redness in the arm of the injection) and VACCINATION SITE REACTION (Sensibility in the arm of injection). At the time of the report, DIARRHOEA (Diarrhea), ERYTHEMA (Redness in the arm of the injection) and VACCINATION SITE REACTION (Sensibility in the arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Menveo error, nurse practitioner who routinely does not administer vaccines, only injected the a part mixed with saline and did not properly reconstitute the vaccine. Post vaccination large subcutaneous nodule formed. Nurse practitioner reporter error but failed to recommend re-vaccination and failure to give data on this error.
had her neck swell up like a balloon; My digestive system has shut down since 11/17; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (had her neck swell up like a balloon) and DYSPEPSIA (My digestive system has shut down since 11/17) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (had her neck swell up like a balloon) and DYSPEPSIA (My digestive system has shut down since 11/17). At the time of the report, SWELLING (had her neck swell up like a balloon) and DYSPEPSIA (My digestive system has shut down since 11/17) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-Dec-2021: Follow-up received and it contains no significant information. On 27-Dec-2021: Follow-up received and it contains significant information a new event added
extreme fatigue, extreme body aches, low-grade fever of 100.2 for 12-24 hours;  swelling in the armpit lymph glands with soreness still present 72 hours
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 23-JUL-2015 the patient was vaccinated with a dose of VARIVAX (Merck) (lot # K018959, expiration date 15-OCt-2016, dose and frequency were not reported), which was improperly stored. No adverse symptoms were reported. This is one of several cases received from the same source. Additional information has been requested.